What we're reading, October 27, 2015: a much-improved Healthcare.gov website, report says drug prices rose at a much slower rate in 2015, and USPSTF recommends glucose testing in asymptomatic adults who are overweight or obese.
Newly Remodeled HealthCare.gov Site More User Friendly
The new website, reports The New York Times, has worked as the government promised, during the third open enrollment season. A new feature this year is a cost calculator that helps would-be enrollees compare different health plans based on their estimate of low, medium, of high use of medical services in 2016, though it does not let users sort plans based on total costs.
Read more here: http://nyti.ms/1k73ejo.
2015 Sees a More Gradual Slope to Prescription Drug Prices
A new analysis by the healthcare technology firm Truveris, reports that prescription drug prices rose 9.1% through September 30, 2015, for all medicines, compared with 10.9% seen in 2014. This information is based on the company’s analysis of claims data that included more than 300 million prescription payments to US pharmacies. The claims data does not account for drug rebates, coupons, or copay cards.
Read more here: http://bit.ly/208u4bH.
USPSTF Recommends Screening for Glucose and T2DM in Overweight and Obese Adults
The U.S. Preventive Services Task Force (USPSTF), as part of cardiovascular risk assessment in obese and overweight adults 40 to 70 years of age, has recommended screening for blood glucose levels. Additionally, the USPSTF recommendation urges physicians to refer patients with abnormal glucose levels to behavior counseling to ensure a healthy diet and incorporating physical activity in their daily life.
Read the paper published in the Annals of Internal Medicine here: http://bit.ly/1N38TCJ.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More